Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Safety Study of EF-022 ( Modified Vitamin D Binding Protein Macrophage Activator) in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Clinical Trial of Uncaria Tomentosa (Cat´s Claw) in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
An Open-label Phase I Study of Orally Available Novel Small-molecule Fibroblast Growth Factor Receptors (FGFR) 1,2,3 and 4 Inhibitor, ASP5878 at Single and Multiple Doses in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Cardiac Safety Study of TH-302 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study of DS-8895a in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments
- Status
- UNKNOWN
- Phase
- PHASE4
Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1b Maintenance Therapy Study of ONT-10 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess Pharmacokinetics, Immunogenicity and Safety/Tolerability of Patritumab (U3-1287)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
Japanese Phase 1 Trial of Sym004 in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 or A*02-positive Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2